← Eichor
Study identifier: NCT06056271 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation

Condition: Atrial Fibrillation  ·  Sponsor: Volta Medical

PhaseN/A
Planned participants400
Who can joinAll sexes, 21 Years to no upper limit
Healthy volunteersNo

About this study

Observational, multi-center, clinical device registry for US patients with a primary goal to observe the clinical outcomes in patients who are mapped with Volta Medical's VX1 or AF-Xplorer systems during AF ablation procedures.

This description comes directly from the study's public registry record.

Talk to the study team

Daniel Guerrero  ·  612-227-1483  ·  daniel.guerrero@volta-medical.com

Always discuss trial participation with your own doctor first.

Locations (4)

Endeavor HealthEvanston, Illinois, United StatesRecruiting
Kansas City Cardiac Arrhythmia Research LLCOverland Park, Kansas, United StatesRecruiting
Northwell HealthNew York, New York, United StatesRecruiting
Ohio State UniversityColumbus, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06056271